Qureight will integrate its deep-learning technology into the study, providing imaging core lab services.

Sphere Fluidics today announced its rebranding to Sphere Bio. The name change marks a significant milestone in the company’s development, reflecting its transition from a leading droplet-based microfluidics innovator to an established commercial provider of integrated life sciences tools and solutions.

Neuroscience startup Monument Therapeutics has developed MT1988, a novel fixed-dose combination drug for the cognitive impairment associated with schizophrenia.

Nearly 20 subjects in the US are being enrolled for the trial.

Oxford Drug Design has been awarded £1 ($1.2) million in funding to progress its uUTI (uncomplicated urinary tract infection) antibacterial programme from PACE (Pathways to Antimicrobial Clinical Efficacy).

Cambridge-based FLIT, an engineering company that builds folding electric bikes for urban commuters, has raised £1.2 million in new funding. The cash injection will be used to scale up production of its latest model, the FLIT M2 at the company’s Cambridge facility.

The Newcastle University spinout will use the funds to develop the company’s sales and drive widespread adoption of its biological transport technology.

Anglo / German partnership harnesses AI to redefine market intelligence for total innovation

Qureight Ltd, the Core Imaging Laboratory developing deep-learning image analytics, and Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on developing inhaled therapies to treat life-threatening pulmonary diseases, have announced the initiation of a strategic partnership in progressive pulmonary fibrosis.

Forecasting and planning specialist now provides its Control Tower customers with tailored reports summarising their data on demand, sales, operations and crop availability

Paragraf, a UK-based company leading the way in mass-producing graphene-based electronics using standard semiconductor processes, has been awarded a £419,419 grant from Innovate UK.

Dr Siân Fussell, CTO and co-founder of Bristol-based Albotherm, has been named one of the 50 winners of the Innovate UK Women in Innovation Awards 2025.